Advertisement
-
-
Applications of SGLT2 inhibitors beyond glycaemic control
Here, the authors discuss the beneficial effects of sodium–glucose cotransporter 2 (SGLT2) inhibitors for a range of clinical outcomes beyond glucose lowering, including kidney and cardiovascular protection. They also discuss the need for implementation and adherence initiatives to help translate the benefits of these agents into real-world clinical outcomes.
-
-
Trending - Altmetric
-
Paradigms of acute kidney injury in the intensive care setting
-
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges
-
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential
-
Pathogenic cellular and molecular mediators in lupus nephritis